ACEi ARB Withdrawal in CKD Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Angiotensin Receptor Blockers
- Angiotensin-converting Enzyme Inhibitor
- Blood Pressure
- Chronic Kidney Disease
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03957161
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Elaine Ku, MD University of California, San Francisco Principal Investigator: Raymond Hsu, MD University of California, San Francisco